Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases

The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a higher pH than the rest of the gastrointestinal tract (GIT) and this ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Ruíz, Eva, Álvarez-Álvarez, Covadonga, Peña, M Ángeles, Torrado-Salmerón, Carlos, Dahma, Zaid, de la Torre-Iglesias, Paloma Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322124/
https://www.ncbi.nlm.nih.gov/pubmed/35890399
http://dx.doi.org/10.3390/pharmaceutics14071504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322124/
https://www.ncbi.nlm.nih.gov/pubmed/35890399
http://dx.doi.org/10.3390/pharmaceutics14071504

Ejemplares similares